Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The last time I spoke about Replimune Group, Inc. (REPL), it was with a Seeking Alpha article entitled "Replimune: Further Uncertainty Of RP1 Warrants Move To 'Hold' Rating." With respect to this ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
If you're considering joining the military, here are the top 10 things you should know before you step into a recruiter's office. Joining the military is often a life-defining decision. Your greatest ...
Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. RP1 demonstrates real antitumor activity and durable ...
If JavaScript is not working, refreshing, or loading in the Google Chrome browser, this guide will help you fix the issue. This problem might occur on a specific website or all websites. Either way, ...
President Donald Trump has placed a new condition on a nuclear agreement with Saudi Arabia a day after formally approving it, saying the country now must join the Abraham Accords. Trump wrote in a ...
Sporting CP have reportedly launched a €20 million (A$32.5m) move for Australian star Nestory Irankunda, with the Portuguese giants determined to beat a host of European clubs to the Socceroos forward ...
The president’s new condition could create a roadblock to the agreement his administration announced this week. By David E. Sanger and Karoun Demirjian Reporting from Washington A day after the United ...
Hosted on MSN
Why is REPL stock soaring 127% after hours today?
・The panel voted 10-3 that the results from a key clinical study of the company’s therapy, known as RP1, were both reliable and clinically meaningful for certain patients with advanced melanoma. ・RP1 ...
CP is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of CP shares has decreased $0.42 since the market last closed. This is a 0.45% drop.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results